Sanofi Consumer Healthcare U.S. to launch new Zantac 360°

Print Friendly, PDF & Email

BRIDGEWATER, N.J.— Sanofi Consumer Healthcare U.S. has introduced Zantac 360° with famotidine, an all-in-one heartburn medicine that is said to  give consumers the flexibility to prevent or relieve heartburn fast.

Zantac 360° contains the active ingredient famotidine, a clinically proven, safe, and effective medicine that is FDA approved, and the No. 1 doctor recommended O-T-C H2 blocker approved to both prevent and relieve heartburn.  Zantac 360°can be taken in as little as 15 minutes before eating or drinking to prevent heartburn, or after symptoms develop to relieve it.

Famotidine has a well-established safety profile and Zantac 360° has been tested and shown to be free of the contaminate that led to the voluntary recall of Zantac OTC products containing ranitidine in October 2019.

Zantac 360° will be available at food, drug and mass retailers and ecommerce/online retailers nationwide.



Comments are closed.